BRIDGEBIO PHARMA INC

Ticker: BBIO CUSIP: 10806X102 Class: EQTY

Rhenman & Partners Asset Management AB's Holding History (CIK: 0001599882)

Note: Option positions (PUT/CALL) are excluded.

Q4 2025
Shares 81,600 Value ($000) $6,242 Avg Close $65.64 Range $51.85 - $78.44
Q3 2024
Shares 268,000 Value ($000) $6,823 Avg Close $26.25 Range $23.40 - $32.06
Q2 2024
Shares 184,500 Value ($000) $4,673 Avg Close $27.34 Range $21.62 - $31.43
Q1 2024
Shares 104,500 Value ($000) $3,231 Avg Close $34.01 Range $26.82 - $41.04
Q4 2023
Shares 135,000 Value ($000) $5,450 Avg Close $30.03 Range $23.62 - $44.32
Q3 2023
Shares 135,000 Value ($000) $3,560 Avg Close $28.38 Range $16.61 - $36.36
Q2 2023
Shares 135,000 Value ($000) $2,322 Avg Close $15.05 Range $12.75 - $18.18
Q1 2023
Shares 135,000 Value ($000) $2,315 Avg Close $11.66 Range $7.10 - $19.95